SYNA · Synaptics Incorporated

Current Thesis

Synaptics' fixed-ratio merger with onsemi remains the central thesis, which succeeds if the transaction completes on announced terms before a weekly close below $90 invalidates the price structure. The 2026-06-25 agreement specifies consideration of 1.350 onsemi shares per Synaptics share; the companies described an expected mid-2027 completion, subject to approvals. Merger announcement

The material clarification since the September 6 assessment is procedural: Synaptics' 2026-09-15 definitive proxy explicitly separates its annual-meeting proposals from approval of the pending merger. That document does not establish a merger-vote date. September 15 proxy

As an inference, the narrative is maturing — the June 25 agreement has progressed through the August 12 US antitrust waiting-period termination, while the September 15 proxy still concerns ordinary governance. This describes transaction progress, not measured investor participation. A definitive merger-vote notice would supersede the present calendar uncertainty. August merger update

Bullish and bearish views on Synaptics Incorporated

The model's bull view on Synaptics Incorporated (SYNA), in brief: US waiting period has ended. The Federal Trade Commission granted early termination under the Hart-Scott-Rodino Act on 2026-08-12. The accompanying filing continued to identify stockholder approval and other regulatory clearances as outstanding conditions. Merger update… The bear view: Price performance remains weak. The supplied adjusted market series records a $93.11 close on 2026-09-18 and a three-month decline of 35.2%. These observations do not establish whether the merger discount widened, because a corresponding onsemi close is missing. Consideration… Both cases follow in full.

Bull Case

• US waiting period has ended. The Federal Trade Commission granted early termination under the Hart-Scott-Rodino Act on 2026-08-12. The accompanying filing continued to identify stockholder approval and other regulatory clearances as outstanding conditions. Merger update
• Contractual consideration remains explicit. The 2026-06-25 agreement specifies 1.350 onsemi shares for each Synaptics share at completion. This gives the completion thesis a defined outcome, although the dollar value remains dependent on onsemi's share price. Synaptics merger filing

Bear Case

• Price performance remains weak. The supplied adjusted market series records a $93.11 close on 2026-09-18 and a three-month decline of 35.2%. These observations do not establish whether the merger discount widened, because a corresponding onsemi close is missing.
• Consideration has market exposure. Under the exchange ratio announced on 2026-06-25, lower onsemi shares would reduce the transaction's dollar value even if completion remained probable. Transaction certainty alone cannot establish price recovery. Merger announcement
• Finance leadership remains transitional. Synaptics' 2026-08-21 announcement assigns principal-financial-officer responsibilities to CEO Rahul Patel through completion and states that no successor chief financial officer search is underway. Former chief accounting officer Kermit Nolan is consulting, so the departure of Ken Rizvi does not establish an absence of finance support. Company announcement

Setup & Price Structure

The measured reference is the supplied 2026-09-18 adjusted close of $93.11. The same snapshot places the shares 36.9% below their 52-week high. No moving-average series is available, so a rising-average support claim is unsupported.

The $90 level remains the research invalidation threshold published on 2026-09-06; the available observations do not establish it as a repeatedly tested support shelf. A weekly close below $90 would end the price thesis regardless of whether the merger agreement remained in force.

Positioning evidence is incomplete. Synaptics' filing index lists a Form 4 filed on 2026-09-18 covering a September 17 document date, but the listing alone does not establish discretionary insider selling. Retail participation, short interest and transaction details are unavailable; no crowding conclusion follows. Form 4 listing

Catalyst Calendar (next 30 days)

• 2026-09-30 — Finance transition milestone. Ken Rizvi's advisory employment ends on the date specified in the 2026-08-21 company announcement. This is an administrative milestone, with no stated connection to merger approval. Company announcement

No confirmed merger-vote or registration-effectiveness date is established for 2026-09-20 through 2026-10-20 by the available evidence. The September 15 annual proxy expressly separates its proposals from the merger; it cannot supply the missing transaction calendar. Definitive proxy

What Would Change Our Mind

The price structure breaks on a weekly close below $90, the public research boundary retained from 2026-09-06. Such a breach would invalidate this thesis without, by itself, proving regulatory failure or termination. A company filing announcing termination would separately eliminate the contractual completion case described in the June 25 agreement.

The positive resolution is completion at the announced exchange ratio before that price condition occurs. A definitive merger-vote notice or additional regulatory clearance would strengthen the evidence along the way; neither substitutes for completion. The low-conviction assessment reflects the 2026-09-18 price weakness and the absence of a verified merger-vote date in the available September filings.

Correlation Notes

This is a single-name merger situation with contractual exposure to onsemi under the 2026-06-25 exchange ratio. No current group-theme evidence establishes a separate semiconductor or artificial-intelligence momentum thesis. The contractual link is observable; a realized return correlation is not supplied. Merger terms

A same-date onsemi close is missing for the 2026-09-18 Synaptics reference. Consequently, the current transaction discount and the division of price weakness between acquirer movement and merger risk remain unmeasured.